| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.004 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.007 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |